Neuromod Devices, a medical technology firm focused on tinnitus therapies, has introduced its Lenire device to the Canadian market.

Initially, Lenire will be offered through select hearing care clinics specializing in tinnitus across Ontario, British Columbia, Alberta, Manitoba, and Québec. The rollout begins with availability in 21 clinics, with plans to expand further in 2026.

Lenire is the first bimodal neuromodulation system shown in multiple clinical studies to deliver lasting relief from tinnitus. The treatment works by pairing gentle electrical stimulation applied to the tongue via an intra-oral component called Tonguetip with sound-based stimulation, encouraging beneficial changes in brain activity associated with tinnitus.

Tinnitus—often described as ringing, buzzing, or hissing in the ears—is widespread in Canada. According to the Canadian Health Measures Survey, 43% of Canadians have experienced it at some point, and 37% reported symptoms within the past year.

Dr. Ross O’Neill, Founder and CEO of Neuromod, noted that growing demand from Canadians living with tinnitus has driven the device’s launch. He emphasized the company’s commitment to providing clinically validated solutions and collaborating with leading clinics to expand access to care.

The Canadian introduction follows a thorough audit confirming Neuromod’s compliance with ISO13485 standards and regulatory requirements, including approval from Health Canada.

Canada becomes the latest country to offer Lenire in 2026, following successful launches in markets such as the Netherlands, Portugal, and expanded availability in the United States. Lenire is also the first non-invasive bimodal neuromodulation device for tinnitus to demonstrate effectiveness in both controlled clinical trials and real-world patient outcomes.

In 2023, the device received De Novo authorization from the U.S. Food and Drug Administration (FDA), marking a regulatory milestone. This approval was based on results from the TENT-A3 clinical trial, which showed Lenire to be more effective than sound therapy alone. Following FDA clearance, the device also met the requirements of the Medical Device Single Audit Program (MDSAP) and obtained authorization from Health Canada in late 2025.

Neuromod has since been training hearing care professionals across Canada to deliver Lenire treatment. Findings from the TENT-A2 clinical trial, published in Nature – Scientific Reports, showed that 95% of compliant patients experienced improvement, with 91% maintaining benefits for at least a year after treatment.

Ron Abish, Founder and CEO of Hearing Solutions, highlighted the growing number of patients seeking help for tinnitus and welcomed Lenire as an additional, evidence-backed treatment option.

Real-world data further supports the device’s effectiveness. Studies published in Nature Communications Medicine and the American Journal of Audiology reported significant symptom reduction among patients treated at independent clinics, with a large majority experiencing meaningful relief.

Patients have also shared positive outcomes. Toronto resident Jim Gray described Lenire as life-changing, noting that it helped him reduce reliance on sleep medication and manage his tinnitus more effectively.

Reflecting its strong clinical evidence, Lenire has been recognized by the charity Tinnitus UK as a leading treatment option in terms of safety and effectiveness.

In Canada, Lenire is available exclusively through trained hearing care clinics, where patients undergo an assessment to determine suitability before beginning treatment.

Click here to find a clinic providing Lenire in Canada.

Alana Schreiber, a 27-year-old mother, recently shared her experience of living with a dynamic disability on social media. She describes how her symptoms can vary in intensity and unpredictability. On some days, she is able to dance with her baby to music, while on others, she struggles to even lift her infant son. Simple tasks such as grocery shopping and cooking can be manageable at times, but there are also days when she is unable to get out of bed and requires extended periods of rest. Alana explains that having a dynamic disability means that the severity of her symptoms can fluctuate from day to day or even hour to hour.
 
“Just because you see someone do something one day, doesn't mean they don't struggle with it at other times,” she said.
 
In her post, Alana Schreiber highlights Disability Pride Month, but she regularly updates her followers on her health journey throughout the year. With a combined following of over 100,000 on Instagram and TikTok, she shares tips and tricks she has learned along the way, including how Walgreens helps her stay on track.
 
Despite experiencing health issues for most of her life, Alana only received concrete diagnoses a few years ago. As a child, she suffered from frequent constipation and unexplained allergic reactions. Chronic back and neck pain became a problem after she was involved in a car accident at the age of 12.
 
“I spent my childhood and adolescence feeling othered and different,” she said.
 
Alana Schreiber’s friends encouraged her to share her health journey on social media. When she did, she was surprised to find that many people were unaware of her conditions. She realized that there were many misconceptions about chronic illness, disability, and medical devices, and she wanted to change the way people thought about them. She also discovered an online community of people who understood what she was going through.

Sharing her health journey online has been a two-way street for Alana. She shares her experiences and the community offers her support and education. She has learned a lot about the disabled and illness communities and feels like she is becoming a better person.

One thing Alana has shared with her followers is how the Walgreens app has helped her manage her conditions. She uses the app’s services, such as scheduling same-day delivery of her prescriptions and the medication reminder tool. The app’s Pharmacy Chat feature even helped her discover that an over-the-counter medication was causing a reaction with one of her daily prescriptions.

Alana was feeling nauseous and vomiting and couldn’t figure out what was wrong. On a whim, she decided to try Pharmacy Chat, a 24/7 online feature that allows patients to chat with a Walgreens pharmacy team member. After entering the medications she was taking, the expert told her that one of her medications, when mixed with ibuprofen, could cause vomiting. This saved her a call and a trip to her GI doctor.

What’s next for Alana? She’s moving from Seattle back to California, her home state. She’s sure to update her followers on this soon. To those who are struggling, Alana says to keep going and find joy where you can. Living with a dynamic disability can be like riding a roller coaster - it has its ups and downs and can be confusing. But Alana encourages others to just try riding the ride.